Bioray Laboratories
Clinical trials sponsored by Bioray Laboratories, explained in plain language.
-
New 'Living Drug' trial offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowThis early-stage trial is testing the safety and finding the right dose of a new type of CAR-T cell therapy called BRL-201 for adults with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to standard treatments. Doctors will collect a patient's own immune cells,…
Phase: PHASE1 • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Early trial tests 'Off-the-Shelf' cell therapy for tough lymphoma cases
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called universal CAR-T for adults with B-cell non-Hodgkin lymphoma that has returned or not responded to other treatments. Doctors will give a single dose of these specially engineered immune cells to 3-6 patients to ch…
Phase: NA • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Universal Cancer-Fighting cells tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether a new type of cancer treatment called universal CAR-T cells is safe and effective for adults with multiple myeloma that has returned or stopped responding to other treatments. The treatment uses specially engineered immune cells from donors (not the …
Phase: NA • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC